These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8137252)

  • 1. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
    Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
    Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731).
    Woessner RD; Loudy DE; Wallace CD; Montgomery LR; Cross-Doersen DE; Bush TL; Lewis MT; Prakash N; Bitonti AJ; Wright PS
    Oncol Res; 1997; 9(10):543-52. PubMed ID: 9507532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts.
    Wright PS; Cross-Doersen D; Th'ng JP; Guo XW; Crissman HA; Bradbury EM; Montgomery LR; Thompson FY; Loudy DE; Johnston JO; Bitonti AJ
    Exp Cell Res; 1996 Jan; 222(1):54-60. PubMed ID: 8549673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of human colon and prostate tumor xenografts to (E)-2'-deoxy-2'-(fluoromethylene) cytidine, an inhibitor of ribonucleotide reductase.
    Bitonti AJ; Bush TL; Lewis MT; Sunkara PS
    Anticancer Res; 1995; 15(4):1179-82. PubMed ID: 7653997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro.
    Rose DP; Connolly JM; Liu XH
    Cancer Res; 1994 Dec; 54(24):6557-62. PubMed ID: 7987856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cytotoxic activity of a novel ribonucleoside diphosphate reductase inhibitor MDL-101,731 against thyroid cancer in vitro.
    Kotchetkov R; Krivtchik AA; Cinatl J; Kornhuber B; Cinatl J
    Folia Biol (Praha); 1999; 45(5):185-91. PubMed ID: 10730887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
    Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
    Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
    Anderson WA; Perotti ME; McManaway M; Lindsey S; Eckberg WR
    J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis.
    Zhang RD; Fidler IJ; Price JE
    Invasion Metastasis; 1991; 11(4):204-15. PubMed ID: 1765433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor.
    Piepmeier JM; Rabidou N; Schold SC; Bitonti AJ; Prakash NJ; Bush TL
    Cancer Res; 1996 Jan; 56(2):359-61. PubMed ID: 8542592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice.
    Sun LQ; Li YX; Guillou L; Mirimanoff RO; Coucke PA
    Cancer Res; 1997 Sep; 57(18):4023-8. PubMed ID: 9307288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
    Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
    Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.
    Lee-Huang S; Huang PL; Sun Y; Chen HC; Kung HF; Huang PL; Murphy WJ
    Anticancer Res; 2000; 20(2A):653-9. PubMed ID: 10810336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.